Suppr超能文献

种族对预测非酒精性脂肪性肝病的非侵入性评分准确性的影响。

Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.

作者信息

Xia Ming-Feng, Yki-Järvinen Hannele, Bian Hua, Lin Huan-Dong, Yan Hong-Mei, Chang Xin-Xia, Zhou You, Gao Xin

机构信息

Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.

Institute of Chronic Metabolic Diseases, Fudan Unversity, Shanghai, China.

出版信息

PLoS One. 2016 Aug 31;11(8):e0160526. doi: 10.1371/journal.pone.0160526. eCollection 2016.

Abstract

OBJECTIVES

Presence of non-alcoholic fatty liver disease (NAFLD) can predict risks for diabetes, cardiovascular disease and advanced liver disease in the general population. We aimed to establish a non-invasive score for prediction of NAFLD in Han Chinese, the largest ethnic group in the world, and detect whether ethnicity influences the accuracy of such a score.

METHODS

Liver fat content (LFAT) was measured by quantitative ultrasound in 3548 subjects in the Shanghai Changfeng Community and a Chinese score was created using multivariate logistic regression analyses. This new score was internally validated in Chinese and externally in Finns. Its diagnostic performance was compared to the NAFLD liver fat score, fatty liver index (FLI) and hepatic steatosis index (HSI) developed in Finns, Italians and Koreans. We also analyzed how obesity related to LFAT measured by 1H-MRS in 79 Finns and 118 Chinese with type 2 diabetes (T2D).

RESULTS

The metabolic syndrome and T2D, fasting serum insulin, body mass index (BMI) and AST/ALT ratio were independent predictors of NAFLD in Chinese. The AUROC in the Chinese validation cohort was 0.76 (0.73-0.78) and in Finns 0.73 (0.68-0.78) (p<0.0001). 43%, 27%, 32% and 42% of Chinese had NAFLD when determined by the Chinese score, NAFLD liver fat score (p<0.001 vs. Chinese score), FLI (p<0.001) and HSI (NS). For any given BMI and waist circumference, the Chinese had a markedly higher LFAT than the Finns.

CONCLUSION

The predictors of NAFLD in Han Chinese are as in Europids but the Chinese have more LFAT for any given degree of obesity than Europids. Ethnicity needs to be considered when NAFLD is predicted using risk scores.

摘要

目的

非酒精性脂肪性肝病(NAFLD)的存在可预测普通人群患糖尿病、心血管疾病和晚期肝病的风险。我们旨在建立一种用于预测世界上最大的民族——汉族人群中NAFLD的非侵入性评分,并检测种族是否会影响该评分的准确性。

方法

在上海长风社区的3548名受试者中,通过定量超声测量肝脏脂肪含量(LFAT),并使用多因素逻辑回归分析创建了一个中国评分。这个新评分在中国人中进行了内部验证,在芬兰人中进行了外部验证。将其诊断性能与在芬兰人、意大利人和韩国人身上开发的NAFLD肝脏脂肪评分、脂肪肝指数(FLI)和肝脂肪变性指数(HSI)进行了比较。我们还分析了79名芬兰人和118名患有2型糖尿病(T2D)的中国人中肥胖与通过1H-MRS测量的LFAT之间的关系。

结果

代谢综合征和T2D、空腹血清胰岛素、体重指数(BMI)和AST/ALT比值是中国人NAFLD的独立预测因素。中国验证队列中的受试者工作特征曲线下面积(AUROC)为0.76(0.73 - 0.78),芬兰人为0.73(0.68 - 0.78)(p<0.0001)。根据中国评分、NAFLD肝脏脂肪评分(与中国评分相比,p<0.001)、FLI(p<0.001)和HSI(无显著差异)确定,分别有43%、27%、32%和42%的中国人患有NAFLD。对于任何给定的BMI和腰围,中国人的LFAT明显高于芬兰人。

结论

汉族人群中NAFLD的预测因素与欧洲人相同,但在任何给定的肥胖程度下,中国人的LFAT比欧洲人更多。使用风险评分预测NAFLD时需要考虑种族因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817f/5007035/1ecaa2128d11/pone.0160526.g001.jpg

相似文献

1
Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.
PLoS One. 2016 Aug 31;11(8):e0160526. doi: 10.1371/journal.pone.0160526. eCollection 2016.
3
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
5
Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population.
Trop Med Int Health. 2023 Oct;28(10):830-838. doi: 10.1111/tmi.13927. Epub 2023 Aug 31.
8
Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.
Medicine (Baltimore). 2015 Oct;94(40):e1682. doi: 10.1097/MD.0000000000001682.
9
Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Hepatol Int. 2020 Sep;14(5):808-816. doi: 10.1007/s12072-020-10065-7. Epub 2020 Jun 22.

引用本文的文献

1
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review.
Diagnostics (Basel). 2023 Oct 26;13(21):3316. doi: 10.3390/diagnostics13213316.
2
Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies.
J Clin Transl Hepatol. 2023 Oct 28;11(5):1212-1227. doi: 10.14218/JCTH.2022.00019. Epub 2023 May 31.
3
Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East Asian populations.
Biomark Med. 2023 Apr;17(8):445-454. doi: 10.2217/bmm-2023-0172. Epub 2023 Jul 14.
4
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma.
Biomedicines. 2023 Apr 4;11(4):1097. doi: 10.3390/biomedicines11041097.
5
Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS.
J Clin Endocrinol Metab. 2023 Oct 18;108(11):2940-2949. doi: 10.1210/clinem/dgad249.
7
Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes.
Front Endocrinol (Lausanne). 2023 Feb 22;14:1124576. doi: 10.3389/fendo.2023.1124576. eCollection 2023.
9
Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.
Front Immunol. 2021 Feb 9;11:634409. doi: 10.3389/fimmu.2020.634409. eCollection 2020.

本文引用的文献

1
I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
Aliment Pharmacol Ther. 2016 Mar;43(5):631-42. doi: 10.1111/apt.13521. Epub 2016 Jan 13.
2
The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese.
J Hepatol. 2015 Jun;62(6):1438-9. doi: 10.1016/j.jhep.2015.01.040. Epub 2015 Feb 14.
4
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.
J Hepatol. 2015 Mar;62(3):657-63. doi: 10.1016/j.jhep.2014.10.010. Epub 2014 Oct 19.
6
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10. doi: 10.1016/S2213-8587(14)70032-4. Epub 2014 Apr 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验